Author:
Gómez Pérez M.,Hernández Segurado M.,Bonilla Porras M.,Bécares Martínez J.
Reference6 articles.
1. Ficha técnica Octagamocta Octapharma. Agencia Española del Medicamento [consultado Nov 2010]. Disponible en: http://www.agemed.es
2. Uptodate Criterio de búsqueda: intravenous inmunoglobulins [consultado Nov 2010]. Disponible en: http://www.uptodate.com
3. Therapy with intravenous immunoglobulins: complications and side-effects;Wittstock;Eur Neurol,2003
4. Thromboembolic complications of intravenous immunoglobulins (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report;Milani;Cases J,2009
5. Safety of intravenous immunoglobulin (IVIG) therapy;Katz;Autoimmun Rev,2007